chr13-110179519-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.2194-98A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0752 in 1,537,726 control chromosomes in the GnomAD database, including 4,688 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.076   (  437   hom.,  cov: 33) 
 Exomes 𝑓:  0.075   (  4251   hom.  ) 
Consequence
 COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -2.40  
Publications
10 publications found 
Genes affected
 COL4A1  (HGNC:2202):  (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014] 
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89). 
BP6
Variant 13-110179519-T-C is Benign according to our data. Variant chr13-110179519-T-C is described in ClinVar as Benign. ClinVar VariationId is 1293322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.113  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COL4A1 | NM_001845.6 | c.2194-98A>G | intron_variant | Intron 29 of 51 | ENST00000375820.10 | NP_001836.3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0759  AC: 11558AN: 152180Hom.:  437  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
11558
AN: 
152180
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0752  AC: 104134AN: 1385428Hom.:  4251   AF XY:  0.0744  AC XY: 51587AN XY: 693370 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
104134
AN: 
1385428
Hom.: 
 AF XY: 
AC XY: 
51587
AN XY: 
693370
show subpopulations 
African (AFR) 
 AF: 
AC: 
2418
AN: 
31906
American (AMR) 
 AF: 
AC: 
5242
AN: 
43998
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
431
AN: 
25546
East Asian (EAS) 
 AF: 
AC: 
5395
AN: 
39236
South Asian (SAS) 
 AF: 
AC: 
5665
AN: 
84134
European-Finnish (FIN) 
 AF: 
AC: 
4538
AN: 
51674
Middle Eastern (MID) 
 AF: 
AC: 
124
AN: 
5648
European-Non Finnish (NFE) 
 AF: 
AC: 
76390
AN: 
1045374
Other (OTH) 
 AF: 
AC: 
3931
AN: 
57912
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 5018 
 10036 
 15053 
 20071 
 25089 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 2844 
 5688 
 8532 
 11376 
 14220 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0760  AC: 11570AN: 152298Hom.:  437  Cov.: 33 AF XY:  0.0777  AC XY: 5783AN XY: 74466 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
11570
AN: 
152298
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
5783
AN XY: 
74466
show subpopulations 
African (AFR) 
 AF: 
AC: 
3166
AN: 
41564
American (AMR) 
 AF: 
AC: 
1331
AN: 
15298
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
69
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
625
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
311
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
981
AN: 
10616
Middle Eastern (MID) 
 AF: 
AC: 
12
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
4874
AN: 
68018
Other (OTH) 
 AF: 
AC: 
165
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 570 
 1140 
 1711 
 2281 
 2851 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 140 
 280 
 420 
 560 
 700 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
336
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.